Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer

NCT03540199 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No participant enrolled

Conditions

Advanced Kidney Cancer

Interventions

BIOLOGICAL: Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Kidney Cancer
PROCEDURE: cryotherapy

Sponsor

Fuda Cancer Hospital, Guangzhou

Collaborators

[object Object]